Arc Air inactivates up to 99% of certain airborne microbes in a single pass. It’s designed to inactivate the viruses, bacteria, and fungi floating in our shared spaces with the same proven, hospital-grade 254 nm UV-C disinfection technology as Arc.
The Arc Air has been certified as an FDA Class II Medical Device. Its efficacy has been validated by independent laboratory testing in Northeast Laboratories, Inc., an FDA, USDA, EPA, and NELAP accredited lab in Berlin, CT. The independent testing confirmed the capabilities of the Arc Air to inactivate aerosolized bacteria; all four test bacteria demonstrated to have removal rates in excess of 99%.
This table shows the calculated inactivation rates of common bacteria and viruses based on the mean UV dosage of 4.1 mJ/cm² applied to the four test bacteria. For influenza A (H1N1), MRSA, and SARS-CoV-2 viruses, the inactivation rate is calculated to be in excess of 99% per pass. Subsequent passes through the chamber will result in higher inactivation rates.